mRNA |
Axitinib |
FIMM |
pan-cancer |
AAC |
-0.018 |
0.9 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.0032 |
0.9 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |